Flanders Innovation and Entrepreneurship rewards Indigo a grant to support the development its next generation CGM device

December 1, 2018

Flanders Innovation & Entrepreneurship (Vlaio) stimulates innovation in Flanders and therefore finances research and development (R&D) by Flemish companies. Indigo has been allocated the R&D grant Senza to continue its development of the next generation CGM device.

CEO Danaë Delbeke:

“Senza is geared towards strengthening Indigo’s mission of returning diabetics and their loved ones the control of their life. Senza targets removing the main reasons why patients do not stay with their CGM or don’t even consider using one, even though a substantial health benefit is clinically proven. We are proud to be granted this exclusive recognition by Vlaio.”